PubMed · 2005 · 24 citations · 0 references
MedicinePediatricsPharmacotherapyChild PsychiatryPediatric PharmacotherapyPsychopharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepression PharmacotherapyPediatric PsychopharmacologyPsychopharmacology In AdolescentsPsychopharmacology In ChildrenAntidepressant MedicationsPediatric Antidepressant TherapyPediatric Antidepressant TreatmentPediatric Antidepressant UsePediatric Depression PharmacotherapyPediatric Mood DisordersSelective Serotonin Reuptake Inhibitor TreatmentSelective Serotonin Reuptake Inhibitor Use
This statement is addressed to prescribers, especially general practitioners, and is intended to provide clinical guidance on the use of selective serotonin reuptake inhibitors (SSRIs) when treating children and adolescents. While treatment of psychiatric and developmental disorders in children may include multiple modalities of therapy, this statement is focussed on medication.